Rapport Therapeutics, Inc Common Stock

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-31
Revenue
$0
$0
$0
Gross Profit
-252
-244
EBITDA
-26,669
-29,244
-26,864
EBIT
-26,925
-29,496
-27,108
Net Income
-26,925
-26,732
-24,063
Net Change In Cash
0
0
0
Free Cash Flow
-17,599
-25,092
-20,528
Cash
251,359
55,067
57,604
Basic Shares
37,931
35,444
19,288

Annual Financials

Values in thousands2025-12-312024-12-312023-12-31
Revenue
$0
$0
$0
Gross Profit
-1,016
-839
-112
EBITDA
-124,082
-77,468
-34,664
EBIT
-125,098
-78,307
-34,776
Net Income
-111,483
-78,307
-34,786
Net Change In Cash
0
0
0
Free Cash Flow
-88,089
-67,233
-28,817
Cash
52,645
56,805
70,169
Basic Shares
46,978
20,738
18,078

Earnings Calls

QuarterEPS
2025-12-31
-$0.72
2025-09-30
-$0.71
2025-06-30
-$0.75
2025-03-31
-$0.68